Anna D. Garrett, PharmD, BCPS, CPP
Published Online: Sunday, July 1, 2007

A recently published randomized, double- blind, placebo-controlled study of 36 patients with stable international normalized ratios (INRs) demonstrated a clinically significant interaction between warfarin and high-dose acetaminophen (2-4 g/day).

Patients were randomized to receive placebo, 2 g of acetaminophen per day, or 4 g of acetaminophen per day. A stable INR was defined as 2 consecutive INRs at least 3 weeks apart that were in the therapeutic range.

Of the 24 patients assigned to an acetaminophen group, 13 had elevated INRs over the course of the 4-week study period. Two patients had elevated INRs in the placebo group.

INRs returned to normal in 83% of patients when acetaminophen was discontinued.

Latest Articles
Police and a CVS pharmacy are on the lookout for a man who stole several boxes of diabetic test strips.
The FDA has approved Merck’s supplemental new drug application for single-dose fosaprepitant dimeglumine for injection.
Diabetes is not a fun condition.
OTC medications can have serious side effects in children if they are not carefully administered.
Latest Issues